PURPOSE: To investigate the feasibility, strategy, and long-term outcome of percutaneous recanalization for combined-type @entity3181 ( @entity3181 ). METHODS: From December 2007 to August 2014, consecutive symptomatic combined-type @entity3181 @entity1 were treated by percutaneous recanalization in our centers. Inferior vena cava (IVC) recanalization was the first-stage treatment for all @entity1 . Recanalization of one hepatic vein (HV) was the second-stage treatment for the selected @entity1 . If the @entity1 had the compensatory and patent accessory HV (AHV), we observed this @entity1 for 7  days after IVC recanalization. If the symptoms of portal @entity101 improved, HV recanalization was not needed. Otherwise, HV recanalization was performed. If the @entity1 had no patent AHV, HV recanalization was performed 3  days after IVC recanalization. Data on technical success, clinical success, and follow-up were analyzed, respectively. RESULTS: Sixty-two symptomatic combined-type @entity3181 @entity1 were enrolled. Technical success of percutaneous recanalization was achieved in 60 @entity1 . Among them, 52 @entity1 had the patent AHV and underwent single IVC recanalization, and 8 @entity1 had no patent AHV and underwent combined IVC and HV recanalization. Clinical success was achieved in all of the 60 @entity1 . Three @entity1 died during the follow-up. The cumulative 1-, 2-, and 4-year survival rates were 98.3%, 96.5%, and 92.7%, respectively. CONCLUSION: Percutaneous recanalization is suitable for most combined-type @entity3181 @entity1 . Treatment strategy can be made according to the situation of AHV. If the @entity1 has the patent AHV, single IVC recanalization is enough. Otherwise, combined IVC and HV recanalization should be performed.

Percutaneous recanalization for combined-type XXXX : strategy and long-term outcome.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity3181 :: ('MESH:D006502', 'Disease') :: ['Budd-Chiari syndrome', 'BCS']
@entity3181 :: (MESH:D006502,Disease) :: ['Budd-Chiari syndrome']
